000 | 01229 a2200325 4500 | ||
---|---|---|---|
005 | 20250516020755.0 | ||
264 | 0 | _c20110614 | |
008 | 201106s 0 0 eng d | ||
022 | _a1473-4877 | ||
024 | 7 |
_a10.1185/03007995.2010.548374 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aNagori, B P | |
245 | 0 | 0 |
_aGeneric drug approval: a US perspective. _h[electronic resource] |
260 |
_bCurrent medical research and opinion _cMar 2011 |
||
300 |
_a541-5 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aChemistry, Pharmaceutical _xlegislation & jurisprudence |
650 | 0 | 4 |
_aDrug Approval _xlegislation & jurisprudence |
650 | 0 | 4 |
_aDrug Utilization Review _xlegislation & jurisprudence |
650 | 0 | 4 |
_aDrugs, Generic _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMedicare _xlegislation & jurisprudence |
650 | 0 | 4 | _aUnited States |
650 | 0 | 4 |
_aUnited States Food and Drug Administration _xlegislation & jurisprudence |
700 | 1 | _aMathur, V | |
700 | 1 | _aGarg, S | |
773 | 0 |
_tCurrent medical research and opinion _gvol. 27 _gno. 3 _gp. 541-5 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1185/03007995.2010.548374 _zAvailable from publisher's website |
999 |
_c20503468 _d20503468 |